Joshi VB, Behl S, Pittock ST, et al. - This study was sought to present the structure of the pediatric fertility preservation (FP) program and share safety and patient satisfaction data. Researchers designed FP programs operate under prospective research protocols approved by the Mayo Clinic Institutional Review Board. In this study, 38 ovarian tissue cryopreservation and 37 testicular tissue cryopreservation patients between 0-17 years of age who have been diagnosed with a fertility-threatening condition and/or are scheduled to undergo gonadotoxic treatment were included. There were no serious adverse events that have been reported following surgery. As per the findings, 100% of parents felt that FP was a good decision according to n = 34 one-year follow-ups. The data implies FP is safe and improves the quality of care provided to pediatric patients for their fertility-threatening diagnoses and/or treatments.